Your search returned 7 results.

Results
	1.	Comparison of S-1 plus oxaliplatin (SOX) and capecitabine plus oxaliplatin (XELOX) as adjuvant chemotherapies for stage II and III gastric cancer after D2 resection: A single-center retrospective study. [electronic resource] by Jiang, Zhichao Sun, Yongkun Zhang, Wen Cui, Chengxu Yang, Lin Zhou, Aiping Producer: 20200731 In: Asia-Pacific journal of clinical oncology vol. 16 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	2.	Outcome of chemotherapy with or without targeted agents in metastatic colorectal cancer patients with deficient DNA mismatch repair: A single center, cohort study. [electronic resource] by Yu, Yue Ying, Jianming Zhang, Wen Li, Weihua Sun, Yongkun Yang, Lin Cui, Chengxu Zeng, Yixin Zhou, Aiping Producer: 20190705 In: Asia-Pacific journal of clinical oncology vol. 15 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	3.	Nab-paclitaxel plus S-1 as first-line followed by S-1 maintenance for advanced pancreatic adenocarcinoma: a single-arm phase II trial. [electronic resource] by Zhang, Wen Du, Chunxia Sun, Yongkun Yang, Lin Cui, Chengxu Jiang, Zhichao Wang, Chengfeng Wang, Jinwang Zhou, Aiping Producer: 20190729 In: Cancer chemotherapy and pharmacology vol. 82 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	4.	XELIRI compared with FOLFIRI as a second-line treatment in patients with metastatic colorectal cancer. [electronic resource] by Cui, Chengxu Shu, Chang Yang, Yi Liu, Junbao Shi, Shuping Shao, Zhujun Wang, Nan Yang, Ting Hu, Songnian Publication details: Oncology letters Oct 2014 In: Oncology letters vol. 8 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	5.	A study on the association between hyperlipidemia and hypothyroidism and the response to TKIs in metastatic renal cell carcinoma. [electronic resource] by Song, Yan Du, Chunxia Zhang, Wen Sun, Yongkun Yang, Lin Cui, Chengxu Chi, Yihebali Shou, Jianzhong Zhou, Aiping Wang, Jinwan Sun, Yan Producer: 20161213 In: Asia-Pacific journal of clinical oncology vol. 12 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	6.	Body mass index and age are additional prognostic factors in patients with metastatic renal cell carcinoma treated with tyrosine kinase inhibitors. [electronic resource] by Song, Yan Du, Chunxia Zhang, Wen Sun, Yongkun Yang, Lin Cui, Chengxu Chi, Yihebali Shou, Jianzhong Zhou, Aiping Wang, Jinwan Sun, Yan Producer: 20180315 In: Urologic oncology vol. 34 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	7.	UGT1A16, UGT1A73 and UGT1A9*1b polymorphisms are predictive markers for severe toxicity in patients with metastatic gastrointestinal cancer treated with irinotecan-based regimens. [electronic resource] by Cui, Chengxu Shu, Chang Cao, Dandan Yang, Yi Liu, Junbao Shi, Shuping Shao, Zhujun Wang, Nan Yang, Ting Liang, Hao Zou, Shanshan Hu, Songnian Publication details: Oncology letters Nov 2016 In: Oncology letters vol. 12 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)